23andMe Just Went Bankrupt: In a shocking twist for the world of consumer genetics, 23andMe, once the golden child of DNA testing, has filed for bankruptcy and agreed to be acquired by Regeneron Pharmaceuticals for a reported $256 million. The move marks a seismic shift in how your genetic data could be handled — and who gets access to it.
From health reports to ancestry curiosities, over 15 million people trusted 23andMe with their DNA. Now, with Regeneron stepping in, folks are asking: “What’s next for my data — and my privacy?”
23andMe Just Went Bankrupt
| Feature | Details |
|---|---|
| Company Filing Bankruptcy | 23andMe |
| Acquirer | Regeneron Pharmaceuticals |
| Deal Value | $256 million |
| Users Affected | 15+ million customers |
| Main Concerns | DNA privacy, data usage, consent, service continuity |
| Regeneron’s Stance | Honor privacy agreements, court-monitored usage |
| Expected Deal Closure | Q3 2025 |
| Data Deletion Option | Available in user settings |
| Official Website | https://www.23andme.com |
23andMe’s bankruptcy is a cautionary tale of how tech meets biology, and what can go wrong when trust breaks down. With Regeneron stepping in, the future of millions of DNA profiles now hinges on corporate ethics, legal oversight, and public scrutiny.
If you’ve ever taken a DNA test, now’s the time to check your data settings. Because in 2025, privacy isn’t just about cookies on your browser — it’s about the blueprint of your entire being.
What Went Wrong at 23andMe?
From Fame to Flop: The 23andMe Timeline
- 2006: Founded by Anne Wojcicki (yes, the former wife of Google’s Sergey Brin).
- 2013: FDA cracks down on its health reports.
- 2015-2019: Company rebounds, lands pharma partnerships, launches 23andMe+.
- 2023: Massive data breach impacts ~7 million customers.
- 2024: CEO Wojcicki exits after failed buyout.
- 2025: Files for Chapter 11 bankruptcy.
Major Triggers
- Data Breach Disaster: The 2023 hack exposed names, ethnicities, and even relative matches.
- Fading Popularity: Interest in consumer DNA tests dropped 35% since 2020.
- Cash Burn: Costs outpaced revenue for five straight quarters.
What Regeneron Wants with Your DNA
So why would Regeneron, a drug company, want a bankrupt DNA kit maker?
Answer: Your data.
Regeneron is betting that the real value lies in genomic insights — not spit kits. With 15+ million genetic profiles, Regeneron can speed up research on Alzheimer’s, cancer, asthma, and rare diseases.
They’ve Promised:
- To not sell your data.
- To follow your original consent choices.
- To use data solely for research.
- To have oversight by a court-appointed data ethics officer.
But Here’s the Catch
If you ever opted in for research, your anonymized data is already in the mix — and can’t be “taken back.” Even if you delete your account today.
Is Your DNA Still Safe?
Regeneron isn’t Facebook — they have a decent reputation for ethics in research. But there’s still concern among experts and advocates.
What Experts Are Saying
“We’re witnessing a power shift. This is no longer just about consumer curiosity — it’s about control of genomic futures.”
— Dr. Sheila Voss, Harvard Medical School
“A private company owning genetic blueprints of 15 million people? That’s a privacy Rubicon.”
— Eva Galperin, Electronic Frontier Foundation (EFF)
Public Reaction: Users Are Nervous
On Reddit, X (formerly Twitter), and Facebook, reactions from 23andMe customers range from panic to regret.
“Wish I never uploaded my data. Deleting ASAP.” – Reddit user
“So Regeneron owns my DNA now? What did I sign?” – X user
“Deleting account, but they probably already cloned me.” – Facebook comment
How This Stacks Up Against Other Genetic Firms
| Company | Ownership | Users | Privacy Scandals |
|---|---|---|---|
| 23andMe | Regeneron (soon) | 15M+ | Yes (2023) |
| Ancestry.com | Blackstone | 18M+ | None public |
| MyHeritage | Francisco Partners | 6M+ | Data breach in 2018 |
| Helix | Private | 3M+ | Low-risk profile |
23andMe’s downfall may be the first, but it won’t be the last story in the genetic data arms race.
What Can You Do Right Now?
If you’re feeling uneasy, here are some action steps:
Step 1: Log In
Go to your 23andMe account and review your sharing settings under privacy preferences.
Step 2: Download Your Data
Export your raw DNA data in case you want to switch to another provider or just keep a backup.
Step 3: Delete Your Account
Use the “Delete Data” option. Note: It may take 30+ days to process, especially under bankruptcy protocols.
Step 4: Contact Support
Email [email protected] with any data privacy questions or deletion requests.
Ethics vs Innovation: The Billion-Dollar Debate
Is using DNA to find new treatments a noble pursuit or a privacy invasion?
Supporters say this merger could lead to lifesaving medical breakthroughs. Critics fear it sets a dangerous precedent for corporate control of personal biology.
The truth? Probably somewhere in the middle. One thing’s for sure: genetic rights are going to be a hot topic in tech and healthcare law for the next decade.
UAE Partners With Italian Startup To Build AI Supercomputer Powerhouse
Elon Musk’s xAI Just Updated Grok After Controversial Comments Spark Outrage
AI Search Engines Like SearchGPT Are Changing Everything – Check How Your Online Habits Are Affected
Frequently Asked Questions About 23andMe Just Went Bankrupt
Q1. Is my 23andMe health or ancestry report still accessible?
Yes, for now. But Regeneron may change services post-acquisition.
Q2. Can I get my money back?
Unlikely. The company is in bankruptcy; refunds are rare unless specifically included in the settlement.
Q3. Can I opt out of research now?
You can opt out going forward, but past usage may remain in anonymized research.
Q4. What if I’m part of a class-action lawsuit?
Stay tuned to classaction.org or your email for claim notifications.
Q5. Is my genetic data sold to health insurers?
No. U.S. law (GINA and HIPAA) forbids discrimination based on genetic data and unauthorized sales.
